Supernus Pharmaceuticals | SUPN - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Abbott USD 171.85B 13.8B 2026-07
ANI Pharmaceuticals USD 1.75B 24M 2026-03
Aurora Cannabis CAD 193.82M 133.39M 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Canopy Growth CAD 125.74M 431.39M 2026-07
Cara Therapeutics USD 366M 338M 2025-09
Corcept Therapeutics USD 4.32B 654M 2026-03
Eisai JPY 1.42T 110.62B 2026-03
Eli Lilly USD 869.02B 146.97B 2026-03
Novo Nordisk A/S DKK 1.03T 421.31B 2026-03
Pacira USD 915M 149M 2026-03
Perrigo USD 1.31B 604M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Supernus Pharmaceuticals USD 2.98B 126M 2026-03
United Therapeutics USD 25.19B 4.21B 2026-03
Xeris Pharmaceuticals USD 1.11B 112M 2026-07